Noah is the co-founder and CEO of Science 37 and a physician-scientist-entrepreneur. Science 37 transforms the clinical research process, accelerating biomedical discovery and reducing clinical trial costs by shifting the center for research from traditional institutional investigative sites to the patient’s home and local healthcare system. Science37 uses patient-centered technology platform (NORA®) to create metasites™, simplify the process of participating in trials, and connect patients safely and securely to scientists, no matter where they live. For over 10 years Noah has worked on the skin microbiome, parasite immunology, and cancer vaccine development. He also serves as a senior strategic advisor to both VisualDx and Direct Derm.